- Home
- CBNK vs AQST Comparison
CBNK vs AQST Comparison
Compare CBNK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBNK | AQST |
|---|---|---|
| Founded | 1974 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.3M | 529.4M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CBNK | AQST |
|---|---|---|
| Price | $37.63 | $4.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $35.50 | $9.00 |
| AVG Volume (30 Days) | 49.9K | ★ 2.4M |
| Earning Date | 04-27-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 60.85 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | $16.20 | $10.08 |
| Revenue Next Year | $8.52 | $49.60 |
| P/E Ratio | $23.54 | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $26.40 | $2.94 |
| 52 Week High | $38.83 | $7.55 |
Technical Indicators
Market Signals| Indicator | CBNK | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 60.31 |
| Support Level | $34.40 | $4.03 |
| Resistance Level | $38.83 | $4.35 |
| Average True Range (ATR) | 0.89 | 0.22 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 61.04 | 65.04 |
Price Performance
Historical ComparisonAbout CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.